Literature DB >> 15996085

Chronic diffuse sclerosing osteomyelitis treated with risedronate.

Stephen A Wright1, Auleen M Millar, Steve M Coward, Michael B Finch.   

Abstract

We describe a 21-year-old woman with chronic diffuse sclerosing osteomyelitis (CDSO) of the left femur. The patient presented with shortening of the left leg and intractable pain that was unrelieved with conventional analgesia. Radiological imaging and open bone biopsy confirmed the diagnosis of chronic diffuse sclerosing osteomyelitis. Treatment with risedronate was commenced and a dramatic response in the patient's symptoms and biochemical markers of bone turnover was observed. To our knowledge this is the first case of CDSO treated successfully with risedronate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996085

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  Bone marker response in chronic diffuse sclerosing osteomyelitis treated with intravenous ibandronate.

Authors:  D J Armstrong; S A Wright; S M Coward; M B Finch
Journal:  Ann Rheum Dis       Date:  2006-07       Impact factor: 19.103

2.  A rare case: sclerosing osteomyelitis of the frontal bone.

Authors:  Cihan Adanas; Sezai Özkan; Abdurrahman Aycan; Remzi Erten
Journal:  Childs Nerv Syst       Date:  2019-05-26       Impact factor: 1.475

3.  Effects of antiresorptive agents on osteomyelitis: novel insights into the pathogenesis of osteonecrosis of the jaw.

Authors:  Dan Li; Kirill Gromov; Steven T Proulx; Chao Xie; Jie Li; Daniel P Crane; Kjeld Søballe; Regis J O'Keefe; Hani A Awad; Lianping Xing; Edward M Schwarz
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

4.  A 53-year-old man with a sclerosing rib lesion: A case report.

Authors:  Shucai Bai; Huafeng Zhang; Zhijun Li; Dong Li; Hui Li
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.